() is a serious microbe causing dental caries. Mutacin IV is an effective bacteriocin produced by to antagonize numerous non-mutans streptococcal species. However, the posttranscriptional regulation of mutacin IV remains unclear. This study aimed to analyze the effect of small RNA on mutacin IV. The functional prediction suggested that is involved in the production of mutacin IV, an important secondary metabolite. According to RNAhybrid and RNAPredator prediction, the mutacin IV formation-associated gene is a target of . We further analyzed the roles of and in 20 clinical strains with high production of mutacin IV (High-IV group) and lacking mutacin IV (None-IV group). Levels of expression were significantly higher in the High-IV group, whereas the Non-IV group showed relatively higher expression of , with a negative correlation observed between and . Moreover, compared to the mimic negative control (NC) group, expression was decreased at 400-fold overexpression but increased at approximately 1400-fold overexpression. Although the production of mutacin IV in the 1400-fold change mimic group was larger than that in the 400-fold change mimic group, there was no significant difference in the production of mutacin IV between the mimic group and mimic NC group. These results indicate that has a two-way regulation effect on the expression of but that its regulation in the production of mutacin IV is weak.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842362 | PMC |
http://dx.doi.org/10.1007/s12088-019-00820-2 | DOI Listing |
Pathogens
March 2024
Bioresource Utilization Sciences, Nihon University Graduate School of Bioresource Sciences, Fujisawa 252-0880, Kanagawa, Japan.
is a major cariogenic organism because of its ability to form biofilms on tooth surfaces. Bacteriocins produced by (known as mutacins) are indirect pathogenic factors that play a role in the persistence of this microbe in the oral environment. Nattokinase, a subtilisin-like alkaline serine protease, potently inhibits biofilm formation without affecting growth.
View Article and Find Full Text PDFFolia Microbiol (Praha)
December 2023
State Key Laboratory of Oral Diseases, National Clinical Research Centre for Oral Disease, West China Hospital of Stomatology, Sichuan University, No. 14, Section 3 of Renmin Road South, Chengdu, 610041, China.
Dental caries is a biofilm-related disease, widely perceived to be caused by oral ecological imbalance when cariogenic/aciduric bacteria obtain an ecological advantage. Compared with planktonic bacteria, dental plaques are difficult to remove under extracellular polymeric substance protection. In this study, the effect of caffeic acid phenethyl ester (CAPE) on a preformed cariogenic multi-species biofilm was evaluated, which was comprised of cariogenic bacteria (Streptococcus mutans), commensal bacteria (Streptococcus gordonii), and a pioneer colonizer (Actinomyces naeslundii).
View Article and Find Full Text PDFMol Oral Microbiol
June 2023
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
Streptococcus mutans is considered to be a major causative agent of dental caries. VicRK is a two-component signal transduction system (TCSTS) of S. mutans, which can regulate the virulence of S.
View Article and Find Full Text PDFMicrobiol Spectr
February 2023
Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Owing to extensive metagenomic studies, we now have access to numerous sequences of novel bacteriocin-like antimicrobial peptides encoded by various cultivable and noncultivable bacteria. However, relatively rarely, we even have access to these cultivable strains to examine the potency and the targets of the predicted bacteriocins. In this study, we evaluated a heterologous biosynthetic system to produce biologically active nonnative novel lantibiotics, which are modified bacteriocins.
View Article and Find Full Text PDFFront Microbiol
December 2022
Antimicrobial Division, Sano Chemicals Inc., Bryan, TX, United States.
Mutacin 1140 (Mu1140) is a potent antibiotic against Gram-positive bacteria, such as . The antibiotic is produced by the oral bacterium and is a member of the epidermin family of type AI lantibiotics. The antibiotic exerts its inhibitory activity by binding to the cell wall precursor lipid II, blocking cell wall synthesis, and by disrupting bacterial membranes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!